Please use this identifier to cite or link to this item: http://hdl.handle.net/10637/15525

Oncolytic virotherapy in lung cancer


See/Open:
 Oncolytic_InterRev_CellMol_2023.pdf
40,95 kB
Adobe PDF

See/Open:
 Oncolytic_Nista_et_al_InterRev_CellMol_2023.pdf
  Restricted Access

945,8 kB
Adobe PDF
 Request a copy
Title: Oncolytic virotherapy in lung cancer
Authors : Nistal Villán, Estanislao
Rius Rocabert, Sergio
Llinares Pinel, Francisco
Keywords: CancerLung cancerAdenoviruses
Publisher: Elsevier
Citation: Nistal-Villan E, Rius-Rocabert S, Llinares-Pinel F. Oncolytic virotherapy in lung cancer. Int Rev Cell Mol Biol. 2023;379:221-239. doi: 10.1016/bs.ircmb.2023.05.004
Abstract: Lung tumors are one of the most aggressive threats affecting humans. Current therapeutic approaches have improved patients’ survival; however, further efforts are required to increase effectiveness and protection against tumor relapse and metastasis. Immunotherapy presents an alternative to previous treatments that focuses on stimulating of the patient’s immune system to destroy tumor cells. Viruses can be used as part of the immune therapeutic approach as agents that could selectively infect tumor cells, triggering an immune response against the infection and against the tumor cells. Some viruses have been selected for specifically infecting and destroying cancer cells, activating the immune response, enhancing access, amplifying the cytotoxicity against the tumor cells, and improving the long-term memory that can prevent tumor relapse. Oncolytic virotherapy can then be used as a strategy to target the destruction of transformed cells at the tumor site and act in locations distant from the primary targeted tumor site. Some of the current challenges in lung cancer treatment can be addressed using traditional therapies combined with oncolytic virotherapy. Defining the best combination, including the choice of the right settings will be at the next frontier in lung cancer treatment.
URI: http://hdl.handle.net/10637/15525
Rights : http://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
ISSN: 937-6448
Issue Date: 2-Aug-2023
Center : Universidad San Pablo-CEU
Appears in Collections:Facultad de Farmacia





Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.